Participating Faculty

Supplements and Featured Publications, Biologics and Benefit Design, Volume 14, Issue 8 Suppl

This supplement to The American Journal of Managed Care discusses recent research and proprietary analytic tools employers can use to design a benefit plan that is fiscally responsible, yet does not saddle their sickest employees with burdensome out-of-pocket

expenses or restrict members’ access to essential therapies, such as biotechnology-derived treatments. This supplement also includes commentary from several industry leaders regarding their time-tested approaches to developing effective benefit strategies.

Faculty

Robert D. Moroni (Moderator)

Consultant

Saline, Michigan

Barbara J. Hodge

President and CEO

Integrated Therapeutics Institute

Greenfield Center, New York

David Hom

Vice President, Human Resources

Strategic Initiatives

Pitney Bowes

Stamford, Connecticut

Frank Kopenski, ASA, MAAA

Associate Actuary

Milliman, Inc

Brookfield, Wisconsin

Grant D. Lawless, MD, RPh

Executive Director, Corporate

Accounts

Amgen Inc

Thousand Oaks, California

Wayne M. Lednar, MD, PhD

Vice President and Director,

Corporate Medical

Eastman Kodak

Rochester, New York

John J. Mahoney, MD

Corporate Medical Director

Pitney Bowes

Stamford, Connecticut

Michelle Martin

Director, Health and Welfare

Benefits

CBS

New York, New York

Kenneth D.Wells, MD

Corporate Medical Director

El Paso Corporation

Houston, Texas

Vincent J. Willey, PharmD

Vice President, Health Outcomes

Research

HealthCore, Inc

Wilmington, Delaware

Participants

Robert Berglund

Vice President, Employee

Benefits and Insurance

Boyd Gaming Corporation

Las Vegas, Nevada

Raymond J. Brusca

Vice President, Benefits

Black & Decker Corporation

Baltimore, Maryland

Louise Probst, RN, MBA

Executive Director

St. Louis Area Business

Health Coalition

St. Louis, Missouri

Gerald Richerson

Human Resource Manager

Southern Company Services

Atlanta, Georgia

Julie G.Tatum, GBA

Director, Health and Welfare

Benefits

Clear Channel Communications

San Antonio, Texas

Robert C.Wald

Director, Benefits

Smurfit-Stone Container

Corporation

Creve Coeur, Missouri

J. Brooks Watt, MD

Director, Corporate Medical

Services

The Gillette Company

Boston, Massachusetts

Lynn Zonakis, BSN

Director, Health Strategy

and Resources

Delta Air Lines, Inc

Atlanta, Georgia

Faculty Disclosures

These participants report relationships with the following pharmaceutical companies:

Barbara J. Hodge

Consultant/Advisory Board:

Amgen Inc

Grant:

Amgen Inc

Frank Kopenski, ASA, MAAA

Funding Support:

Amgen Inc

Advisory Board:

Amgen Inc

Grant D. Lawless, MD, RPh

Employed by:

Amgen Inc

Stockholder:

Amgen Inc

John J. Mahoney, MD

Advisory Boards:

Merck

Pfizer

Schering-Plough

Honoraria:

Merck

Pfizer

Schering-Plough

PARTICIPATING FACULTY

Michelle Martin

Advisory Board:

Amgen Inc

Honoraria:

Amgen Inc

Robert D. Moroni

Consultant/Advisory Board:

Amgen Inc

Honoraria:

Amgen Inc

Kenneth D.Wells, MD

Advisory Board:

Amgen Inc

Honoraria:

Amgen Inc

Vincent J. Willey, PharmD

Funding Support:

Amgen Inc

Participant Disclosures

These participants report relationships with the following pharmaceutical companies:

Raymond J. Brusca

Advisory Board:

Amgen Inc

Honoraria:

Amgen Inc

Louise Probst, RN, MBA

Advisory Board:

Amgen Inc

Gerald Richerson

Consultant/Advisory Board:

Amgen Inc

GlaxoSmithKline

Novartis

Pfizer

Honoraria:

Amgen Inc

AstraZeneca

Julie G.Tatum, GBA

Advisory Board:

Amgen Inc

Honoraria:

Amgen Inc

Robert C.Wald

Advisory Board:

Amgen Inc

J. Brooks Watt, MD

Advisory Board:

Amgen Inc

Lynn Zonakis, BSN

Advisory Board:

Amgen Inc

Honoraria:

Amgen Inc

Robert Berglund has nothing to disclose.

David Hom and Wayne M. Lednar, MD, PhD, have nothing to disclose.

Amgen

This supplement has been supported by